Drug-induced hypersensitivity syndrome in Japan in the past 10 years based on data from the relief system of the Pharmaceuticals and Medical Devices Agency

Allergol Int. 2017 Apr;66(2):363-365. doi: 10.1016/j.alit.2016.09.003. Epub 2016 Oct 27.

Authors

Yuri Kinoshita¹, Hidehisa Saeki², Akihiko Asahina³, Toyoko Ochiai⁴, Masafumi Iijima⁵

Affiliations

¹ Department of Dermatology, Nippon Medical School, Tokyo, Japan.
² Department of Dermatology, Nippon Medical School, Tokyo, Japan. Electronic address: h-saeki@nms.ac.jp.
³ Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.
⁴ Department of Dermatology, Nihon University Hospital, Tokyo, Japan.
⁵ Department of Dermatology, Showa University School of Medicine, Tokyo, Japan.

PMID: 28277222
DOI: 10.1016/j.alit.2016.09.003

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Adverse Drug Reaction Reporting Systems
Aged
Aged, 80 and over
Child
Child, Preschool
Drug Hypersensitivity Syndrome / epidemiology*
Female
Government Agencies
Humans
Infant
Infant, Newborn
Japan / epidemiology
Male
Middle Aged
Young Adult